Trimax Corp (OTCMKTS:TMXN) Reverses Trend

Trimax Corp (OTCMKTS:TMXN)

Shares of Trimax Corp (OTCMKTS:TMXN) are trading in a strong upward trend in the wake of the company and its wholly owned subsidiary, Saavy Naturals, reporting better than expected Q2 financial results. The stock was up 91.89% in Wednesday’s trading session to end the day at highs of $0.0355 per share.

OTCMKTS:TMXN
One month stock price chart for TMXN

The beauty company has registered five consecutive days of gains. Momentum build-up has helped push the stock from lows of $0.01 a share to current highs of $0.0355 a share. Wednesday’s rally helped reverse a strong downward trend that had pushed the stock to all-time lows. It now awaits to be seen if the stock will continue to edge higher in the wake of the stellar second quarter results.

Trimax Corp (OTCMKTS:TMXN) is a diversified company that offers a wide range of natural skin care products through its subsidiary Saavy Natural. The company also offers application development, technology consulting and cloud services. The company is also involved in organic farming.

Q2 Earnings Report

Trimax Corp (OTCMKTS:TMXN) generated gross revenues of $272,386 in the second quarter, representing a 62% increase from last year levels. Sales were up by 140% in the quarter as the company reported a 44% year to date increase in sales from $305,021 to $440,071.

In a bid to build up the sales momentum, Trimax Corp (OTCMKTS:TMXN) plans to increase marketing efforts around its beauty care products while also focusing on expanding distribution. The company has already signed an agreement that will result in the expansion of the body care line into Gelson’s markets.  Gelson currently operates 25 full specialty stores in Southern California which should expand Trimax distribution footprint in pursuit of triple digit growth.

“We are extremely pleased with the triple digit growth we have been experiencing in 2017. We continue to work aggressively on establishing new channels of product distribution, as well as, reaching out to online consumers directly through various online sales campaigns,” said CEO, Hugo Saavedra.

In addition, the company has confirmed the appointment of Justin Miloro as the new Chief Operating Officer. He joins the company with 25 years of sales and executive management experience expected to be of great help as Trimax Corp (OTCMKTS:TMXN) embarks on an aggressive marketing and distribution diversification strategy.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $TMXN and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Will Helios and Matheson Analytics Inc (NASDAQ:HMNY) Grab Movie Magic?

Helios and Matheson Analytics Inc (NASDAQ:HMNY)

Helios and Matheson Analytics Inc (NASDAQ:HMNY) gapped up to open on Tuesday morning, reached above $3.80, then retreated throughout the day and into today’s session to trade in a tight range around $2.60. Volume has been heavy – almost double the stock’s daily average.

Helios and Matheson Analytics Inc (NASDAQ:HMNY)
One month stock price chart for HMNY

The market is responding to the company’s announcement that it has bought a 51% majority stake in MoviePass, a subscription-based service for movie theaters led by former Netflix executive and co-founder Mitch Lowe. Helios and Matheson Analytics Inc (NASDAQ:HMNY) paid $27 million for the equity.

The two New York city-based companies simultaneously launched a monthly subscription service with a price-point at $9.95. The subscription entitles the subscriber entry into one movie every 24 hours at any of the participating 3,700 U.S. movie theaters. Prior to the deal, subscription plans from MoviePass ranged anywhere from $14 to $50 per month.

Lowe served as the vice president of business development and strategic alliances for Netflix, from 1998 to 2003. He also held executive positions at RedBox Automated Retail LLC from 2005 to 2011, including, for four years, as the company’s CEO. In June of 2016, Lowe was installed as CEO at MoviePass.

The subscription plan is one facet of the company’s strategy to increase movie attendance which has been trending downwards along with the popularity of shopping malls. Enticement include reserved seating, pre-ordering drinks and food, and free large-screen viewing of popular TV shows throughout the day. The new approach was designed to broaden the demographics of movie attendees. Currently over 70% of movie theater viewers are millennials. By offering a more upscale service, Helios and Matheson Analytics Inc (NASDAQ:HMNY) hope to attract a more mature consumer.

One year ago Helios and Matheson Analytics Inc (NASDAQ:HMNY) stock was trading above $13. For the past few months HMNY shares have been trading between $2 and $3. YTD the stock is down only 10% but for the year HMNY shares are down over 67%. Interested investors or traders should note that 15% of the stock’s float is held by short-sellers.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $HMNY and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

BTCS Inc (OTCMKTS:BTCS) Rallies 100.5% Amidst Working Capital Concerns

BTCS Inc (OTCMKTS:BTCS)

Shares of BTCS Inc (OTCMKTS:BTCS) more than doubled in value after rallying by 105.37% as Bitcoin prices continue to hit record highs. The rally comes days after the company announced the appointment of Jonathan R. Read, to the board of directors, as part of an effort that seeks to strengthen the push to create a vertically integrated operation in the block chain space.

BTCS Stock Chart:

BTCS Inc (OTCMKTS:BTCS)
One month BTCS stock price chart

Bitcoin Rally

The BTCS Inc (OTCMKTS:BTCS) stock rally continues to flex its muscles around the cryptocurrency hype. A push by the management to diversify the company’s operations, spanning process transaction and a shift towards initial coin offering, has helped strengthen investor confidence on the stock.

Pursuing opportunities on initial coin offerings is a bold move that could see the company enjoy a first mover advantage as Bitcoin becomes mainstream. Getting a hold of the market which is believed to be worth a half a billion dollars could help BTCS Inc (OTCMKTS:BTCS) enjoy impressive growth in line with the growing demand for crypto currency.

BTCS Capital Challenges

Focusing the business on blockchain technologies has, however, come with its fair share of challenges. A lack of sufficient capital to pursue opportunities with speed poses the biggest challenge as the company tries to realize full potential from the disruptive opportunity.

BTCS Inc (OTCMKTS:BTCS) need significant additional capital to sustain its short term operations and make investments needed execute the long term business plan. Existing liquidity is not sufficient to fund operations and anticipated capital expenditures.

Over the past year, BTCS Inc (OTCMKTS:BTCS) has tried to restructure its liabilities as it seeks to improve its financial position. To date, the company has exchanged approximately $3.9 million of convertible notes and raised $1 million as it sought to raise funds to pay liabilities and raise working capital.

“We have taken these steps because we believe the rise of digital tokens as a new asset class has created a tremendous opportunity for us to leverage our experience in the sector, “BTCS in a statement.

Subject to completion of additional financing BTCS Inc (OTCMKTS:BTCS) plans to create a portfolio of digital assets through initial coins offerings, strategic market purchases. The company is also planning to carry out a number of acquisition across the blockchain space.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $BTCS and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

FIRST BITCOIN CAP COM NPV(OTCMKTS:BITCF) Stock Exploding

FIRST BITCOIN CAP COM NPV(OTCMKTS:BITCF)

FIRST BITCOIN CAP COM NPV(OTCMKTS:BITCF) stock is rocketing. BITCF stock is up over 50% by 1PM EST on heavy volume. First Bitcoin closed on Friday at $1.49. The stock gapped up to open this morning at $1.87 and has hit an inter-day high of $2.40. Over eight million shares of BITCF have traded hands when the listed 30-day average volume figure is just 1.1 million.

FIRST BITCOIN CAP COM NPV(OTCMKTS:BITCF)
One month price chart for BITCF

Today Bitcoin went over the $4,000 mark and Ethereum went over $307. These events likely the reason First Bitcoin’s BITCF stock is rocketing. An analyst from Standpoint Research, Ronnie Moas, raised his bitcoin price target to $7,500 from the current $5,000. He also announced that he expects the total value of the crypto-currency market to total Two Trillion dollars. Bitcoin has more than quadrupled YTD while Ethereum has gained over 3,000%. Not surprisingly, there is an abundance of rumors that institutional investors will soon be entering the markets in a major fashion. It should be noted that Bitcoin represents about 50% of the total value of the crypto-currency market.

FIRST BITCOIN CAP COM NPV(OTCMKTS:BITCF) claims to be the first vertically integrated, publicly traded Bitcoin company. First Bitcoin will pursue it business goals that include the acquisition of Bitcoin start-ups, fund raising, and investing in crypto-currency software and hardware. The company plans to be a player in the following industry sectors:

  • Digital currency mining;
  • Developing digital currency exchanges to provide liquidity to the crypto-currency market;
  • Develop goods and services that will utilize a crypto-currency payment application; and
  • Develop technologies to enhance and develop the digital currency market.

Investors should complete their due diligence before investing in crypto-currencies. There is no regulation as with federally sanctioned stock exchanges. In 2014, trhe world’s largest Bitcoin exchange, Mt.Gox, was hacked and Bitcoin values plummeted over 50% as the hacked exchange had over $500 million worth of Bitcoins stolen from its servers.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $BITCF and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

EnteroMedics Inc (NASDAQ:ETRM) After-Hours News Hits Stock

EnteroMedics Inc (NASDAQ:ETRM)

EnteroMedics Inc (NASDAQ:ETRM) stock was up over 17% in Monday’s after-hours trading session, to end at $4.49, after the company announced a loss of $6.8 million in its second quarter. Revenues came in at $93,000 – less than what was expected. However, on a per-share basis, the St. Paul, MN-based, medical device company lost (-$0.91) which beat street estimates by $0.02.

EnteroMedics Inc (NASDAQ:ETRM)
Six month Enteromedics price chart

Importantly, implantations of the company’s lead revenue generator, the vBloc®, was up over 83% from the same quarter last year. For the six months ended June 30, 2017, the Company placed 50 units, primarily from the vBloc Now program, a 72% increase compared to 29 units for the same period in 2016. As of June 30, 2017, the Company had cash, cash equivalents and short-term investments totaling $11.2 million and it had no debt.

EnteroMedics Inc (NASDAQ:ETRM) is a developer of medical devices that cater to the weight-loss market. The company developed the FDA-approved vBloc® neurometabolic therapy. The vBloc® therapy is delivered by a pacemaker-like device called the Maestro® Rechargeable System. This device is designed to help patients feel full and eat less by intermittently blocking hunger signals on the vagus nerve – thereby allowing patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals. The vBloc® Therapy is a non-anatomy altering or restricting, and is reversible.  therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals.

EnteroMedics Inc (NASDAQ:ETRM)
ETRM’s vBloc FDA-approved weight loss aid/device

Bariosurge Inc. was recently acquired by EnteroMedics Inc (NASDAQ:ETRM) which gave the company an additional revenue stream originating from the weight-loss market. Bariosurge is the developer of the Gastric Vest System™. The Gastric Vest is being developed as a minimally invasive, laparoscopically implanted medical device for weight loss in morbidly obese patients. The device wraps around the stomach, emulating the effect of conventional weight-loss surgery, and is intended to reduce the size of the stomach without permanently changing one’s anatomy.

EnteroMedics Inc (NASDAQ:ETRM) continues to address the primary cause of drag on the stock price – a lack of coverage by major insurance companies. It is important to remember that the stock blasted over 700% on the news that the company had two new facilities agree to be used for device implantation. It appears the market will reward the company for any advancement of its device into the medical mainstream.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $ETRM and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

Medical Transcription Billing Corp (NASDAQ:MTBC) Stock Price Jumps ahead of Earnings

The movement in MTBC stock price is likely due to an upward revision in the company’s revenue guidance for the year coupled with their Q2 financial release scheduled for tomorrow before the market opens.

Medical Transcription Billing Corp (NASDAQ:MTBC)

Medical Transcription Billing Corp (NASDAQ:MTBC) shareholders are enjoying a jump in their stock price of over 30% for the week. The movement in the stock price is likely due to an upward revision in the company’s revenue guidance for the year coupled with their Q2 financial release scheduled for tomorrow before the market opens. Volume for MTBC shares are on pace to exceed seven times their daily average. MTBC stock price chart:

Medical Transcription Billing Corp (NASDAQ:MTBC)
Candlebar stock price chart for MTBC

Before the July 27th announcement, management of Medical Transcription Billing Corp (NASDAQ:MTBC) provided revenue guidance for FY 2017 between $30 – $31 million. That guidance was revised on the 27th and is now pegged between $31 – $32 million. Those revised figures represent a 27% – 31% increase over FY 2016 figures.

Mahmud Haq, MTBC’s Chairman and CEO stated in the press release “We’re very pleased to see our revenue growth outpace our initial full year revenue guidance. Having also achieved our highest adjusted EBITDA as a public company during the second quarter of 2017, we anticipate a remarkable year of achievement for MTBC.”

Medical Transcription Billing Corp (NASDAQ:MTBC) shareholders have had a stellar run with the company. Over the past year, the stock price is up over 53% and is up over 120% YTD. Currently MTBC stock is trading just below $2 or over 500% its 52-week low of $0.29. Importantly, the stock has reached a Relative Strength Index figure of over 72. That level is normally associated with a stock that is overbought.

Medical Transcription Billing Corp (NASDAQ:MTBC) management will host a conference call at 8:30 a.m. EDT on Thursday, August 3, 2017, to discuss the first half 2017 results. The live webcast of the conference call can be accessed under Events & Presentations at ir.mtbc.com or by dialing 412-317-5131 and referencing “MTBC Second Quarter 2017 Earnings Call.” A replay of the conference call will be available approximately one hour after conclusion of the call at the same link. An audio replay can also be accessed by dialing 412-317-0088 and providing access code 10110213.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $MTBC and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Marc has a degree in economics and a MSc. in Finance. Over his 20-year career, Marc has worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.

FDA Committee Vote Boosts Dynavax Technologies Corporation (NASDAQ:DVAX)

Dynavax Technologies Corporation (NASDAQ:DVAX)

Dynavax Technologies Corporation (NASDAQ:DVAX) shares are up over 70% on positive news from the U.S. Food and Drug Administration (FDA) and ratings upgrades from RBC Capital Markets and JP Morgan. The listed average daily volume for DVAX shares is 1.8 million but by 11:40 AM EST, over14.6 million shares had traded.

Dynavax Technologies Corporation (NASDAQ:DVAX)
One month daily candlebar graph for $DVAX

The catalyst for the share increase was news, dated last Friday, that the FDA’s Related Biological Products Advisory Committee (VRBPAC) voted 12 to 1 that for Dynavax’s HEPLISAV-B vaccine’s safety data support licensure for immunization against hepatitis B infection in adults. Established hepatitis B vaccines are administered in three doses over a six-month schedule. The HEPLISAV-B schedule is two doses over one month. Results of a published Vaccine Safety Datalink study showed that only 54 percent of adults completed the three-dose hepatitis B vaccine series in one year. Hepatitis B is a viral liver disease that can lead to cirrhosis of the liver, hepatocellular carcinoma, and death. In the U.S., the number of reported cases of acute hepatitis B increased more than 20 percent in 2015.

Eddie Gray, CEO of Dynavax, stated “Clinical studies of HEPLISAV-B have shown that the vaccine provides increased rates of seroprotection. In addition, the two-dose regimen offers the potential to increase patient compliance, which physicians and advocates agree is essential to preventing more cases of hepatitis B and achieving the public health goal of eradication. We look forward to completing our ongoing discussions with the FDA regarding an appropriate post-marketing commitment as it finalizes its review.”

Over 11% of Dynavax Technologies Corporation (NASDAQ:DVAX) outstanding shares are held short. In 2012 DVAX shares had an EPS loss, adjusted for dilution, of (-$4.10). In the years that followed losses continued but were steadily narrower: (-$3.83), (-$3.45), (-$3.25), and in 2016 the loss was (-$2.92). However, the number of outstanding shares follows a steady upward trend. In 2012 there were 17.05 million outstanding shares. By 2016 that number had steadily grown and stood at 38.51 million.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $DVAX and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Monica has an undergraduate degree in Accounting and an MBA she earned – with Honors. She has six years of experience in the financial markets and has been an analyst for the past two years.

Here’s the deal that sparked shares of Portlogic Systems Inc. (OTCMKTS:PGSY)

Portlogic Systems Inc. (OTCMKTS:PGSY)

Shares of Portlogic Systems Inc. (OTCMKTS:PGSY) shot up in the last session as the market continued to react positively to the news that the company had entered into a strategic partnership with a firm that previously employed its current chief technology officer.

The stock rose more than 17.6% to close at $0.16 after trading between a low of $0.14 and a high of $0.16 during the day. A larger-than-usual stock volume also changed hands in the last session. Nearly 5.2 million shares were traded, significantly higher than the daily average volume of about 1.5 million over the last several months.

Shares of Portlogic Systems Inc. (OTCMKTS:PGSY) have gained more than 172% since the beginning of the year and have climbed 257.9% over the last year.

Portlogic Systems Inc. (OTCMKTS:PGSY)
One month daily candle bar graph for $PGSY

The update that moved the stock

In a press release, Portlogic Systems Inc. (OTCMKTS:PGSY) announced that it had entered into a partnership with Mobicloud Technologies, a company that describes itself as a global interactive software developer.

Portlogic has tapped Mobicloud Technologies to provide IT consulting and help with the development of mobile apps as well as unspecified VoIP products. Mobicloud’s contractual scope includes providing a broad range of cloud-based, end-to-end solutions to Portlogic customers.

Portlogic Systems Inc. (OTCMKTS:PGSY) itself is focused on providing mobile apps, including marketing apps, and telecom solutions. Its customers include enterprises. Therefore, the deal with Mobicloud seems to be aimed at bolstering its position in the sector of mobile communication as it seeks to take advantage of the global proliferation of smartphones.

Financial terms kept under wraps

The financial terms of the agreement weren’t disclosed, but Portlogic Systems Inc. (OTCMKTS:PGSY) pointed out that its current CTO, Meeta Litake, previously worked for Mobicloud.

Of note is that the deal seems to have come soon after PGSY appointed Litake to the CTO position. Litake, who has 18 years of academic and corporate experience in engineering and computer science as well as startup consulting, was made CTO on July 18. In that position, Litake’s roles include developing Portlogic’s technology strategy.

Litake commented on Portlogic Systems Inc. (OTCMKTS:PGSY)’s deal with Mobicloud, saying the arrangement would help Portlogic in building its customer base.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $PGSY and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Key Acquisition for Naked Brand Group Inc (NASDAQ:NAKD)

Naked Brand Group Inc (NASDAQ:NAKD)

Naked Brand Group Inc (NASDAQ:NAKD) shares are up over 30% before lunch on news that it has acquired the sole owner of intimate clothing brand Frederick’s of Hollywood global online license. NAKD shares end Tuesday at $1.26 but before lunch shares had hit $1.82 on a volume figure over 18 times the daily average.

Naked Brand Group Inc (NASDAQ:NAKD)
One month daily candle-bar graph for $NAKD

Naked, Bendon, and Bendon Group Holdings Limited (“Holdco”) recently entered into a merger agreement under which both of Naked and Bendon will become wholly owned subsidiaries of Holdco, a newly formed Australian holding company.

Bendon will acquire all of the outstanding common stock of FOH in exchange for the forgiveness of debt owed by FOH to Bendon. As a result, Bendon will control FOH’s existing license to develop and sell online products under the Fredrick’s of Hollywood name. As part of the transaction, Holdco will issue to FOH shares, which would have otherwise been issued to Bendon at the time of the merger. Most of these shares will be transferred to the affiliate of Bendon which initially funded FOH. The issuance of the Holdco shares is expected to have a minimal impact on the amount of shares Naked Brand Group Inc (NASDAQ:NAKD) stockholders will have in Holdco.

Naked Brand Group Inc (NASDAQ:NAKD) sales have increased each year since 2015 when the company reported $0.6 million in sales. That number was followed by annual sales figures of $1.4 million and $1.8 million. However profit has been harder to grasp for the apparel company. In 2015, Naked Brand Group Inc (NASDAQ:NAKD) shareholders suffered a per share loss of (-$23.33). That loss narrowed in 2016 to (-$10.13), then narrowed again in 2017 to (-$1.77).

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $NAKD and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) Debuts on TSX After German Expansion

AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF)

Shares of AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) jumped 5.31% after the company made its debut on the Toronto Stock Exchange. Trading on Canada’s flagship stock exchange marks yet another milestone achievement for a company that has added more than $600 million in shareholder value and seen its monthly revenues more than triple over the past year.

Aurora Cannabis $ACBFF
Two Month Chart for $ACBFF

Toronto Stock Exchange Milestone

AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) shares are currently trading on the flagship exchange under the symbol ACB. Its shares have also been voluntarily delisted from the TSX Venture Exchange. The upgrade, according to the Chief Executive Officer Terry Booth, reflects the remarkable commercial and operational progress made since late last year.

“We are achieving record yields at our Mountain View County production facility, progressing rapidly with the construction of our 100,000+ kg per annum Aurora Sky facility at Edmonton International Airport, and are executing consistently on our national and international expansion strategy,” said Mr. Booth.

AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) is a licensed producer of medical cannabis with operations in the U.S. and Canada. The company currently operates a 55,200 square foot, state of the art facility from where it develops its proprietary cannabis products. It is also in the process of constructing a second 800,000 square foot production facility as it looks to strengthen its position in the fast growing industry.

AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) is currently in the process of acquiring its third production facility in Pointe Claire, Quebec, to further support domestic growth. In addition to pursuing growth opportunities back at home, Aurora Cannabis is also looking to grow its footprint on the international scene.

Germany Expansion

AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF), through its subsidiary Pedanios, has passed the first application to become a licensed medical cannabis operator in Germany. The subsidiary is set to participate in a second and final stage of the application process. The process involves contract negotiations for cultivation, processing, storing, packaging and delivery of medical cannabis products.

Pedanios is German’s largest importer, exporter, and distributor of medical cannabis. The company has shipped to more than 1,000 German pharmacies. Germany is poised to be one of the biggest markets in medical cannabis given that the country’s healthcare system covers the cost of medical cannabis. A population of more than 80 million people also presents a unique target market that AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) can rely on for sales growth.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $ACBFF and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.